selecting therapy for poor-risk advanced rcc
Published 4 years ago • 31 plays • Length 4:06Download video MP4
Download video MP3
Similar videos
-
4:23
second-line options for poor-risk advanced rcc
-
3:33
poor-risk advanced rcc: tki therapy & outlook
-
3:11
treatment options for intermediate/poor-risk rcc
-
6:17
in rcc, what is the optimal treatment for intermediate/poor-risk disease?
-
5:23
selecting novel therapy for advanced renal cell carcinoma
-
5:25
advanced rcc treatment selection
-
8:57
determining initial therapeutic approach in advanced rcc
-
1:30
targeted therapies for the treatment of mrcc after nivolumab-ipilimumab failure
-
2:13
treating advanced renal-cell carcinoma
-
2:44
surgery for poor-risk advanced renal cell carcinoma
-
38:09
understanding and working with new immunotherapeutic and targeted management models in advanced rcc
-
2:53
case based overview: poor-risk advanced renal cell carcinoma
-
0:54
advances in the development of targeted therapies for renal cell carcinoma
-
9:57
how to select 1st line therapy for metastatic renal cell cancer?
-
6:36
choosing post-progression therapy for metastatic rcc
-
4:06
selecting second-line therapy for metastatic rcc
-
5:12
advanced rcc: prognosis and therapy selection
-
2:53
immunotherapy and targeted therapy for advanced arcc
-
55:12
selecting and sequencing targeted and immunotherapy regimens for patients with rcc